Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Regulation Legislation

Government Agencies Form Work Group To Develop Health IT Framework

This article was originally published in The Gray Sheet

  • News

Executive Summary

The group will assist mandatory efforts by FDA, the Federal Communications Commission and the Office of the National Coordinator for Health Information Technology to issue recommendations for a risk-based regulatory framework for health IT, including mobile medical apps.

You may also be interested in...



HHS Health IT Regulations Work Group Sets Path Forward

A new public stakeholder group met for the first time to begin efforts to advise government agencies on developing a health IT regulatory framework, setting itself an August 7 deadline for final recommendations.

News In Brief

Thermo Fisher acquires Life Technologies. Mako acquires Stanmore Implants as part of a settlement between the robot-makers. More news.

Classifying Health IT Still Key Focus For Digital Health Regulation

Conceptual fuzziness still an issue with regulating health IT, observers agree.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight

Topics

Tags:
Medical Device Regulation Legislation
Latest Headlines

NWW: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients

Getting Personal With Tom Miller: CEO Turned VC On Ethical Bets In Diagnostics

Postmarket Surveillance Continues To Challenge AI/ML Device Regulators

Q&A: Allyson Mullen On ‘Uncharted Waters’ Of Breakthrough Pathway

See All
UsernamePublicRestriction

Register

MT031866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By